齐艳涛,刘会明,李宏宇,柴吉鑫,张浏阳,李波,敖亚洲
QI Yantao,LIU Huiming,LI Hongyu,CHAI Jixin,ZHANG Liuyang,LI Bo,AO Yazhou

• 1:承德医学院附属医院甲状腺外科

摘要(Abstract)：

目的 探讨甲状腺手术围手术期继发性甲状旁腺功能减退致症状性低钙血症(SH)的影响因素以及处理方案。方法 收集行甲状腺全切术后出现SH的患者120例作为SH组，同时期行甲状腺全切术后未发生SH的患者110例作为对照组，采用logistic回归分析术后发生SH及SH患者症状缓解所需补钙剂量的影响因素，并绘制ROC曲线分析术前、术后全段甲状旁腺激素(iPTH)对术后SH患者补钙剂量的预测效能。结果 发生SH的单因素分析显示，女性、术后钙水平、术前iPTH、术后iPTH、术后维生素D水平、术后24 h尿钙水平、病变范围、手术时间、病理诊断是影响术后发生SH的主要因素(P<0.05);SH患者补钙剂量的单因素分析显示补钙量、手术时间、术前iPTH、术后iPTH、术后维生素D水平、术后24 h尿钙水平是影响术后SH患者症状缓解所需补钙剂量的主要因素(P<0.05);多因素分析显示，术前低iPTH、术后低iPTH是影响术后SH患者症状缓解所需补钙剂量的高危因素(P<0.05);Pearson相关性分析发现，术后SH患者症状缓解所需补钙剂量与术前iPTH、术后iPTH均呈负相关(P<0.05),ROC曲线提示术后iPTH<18.19 mmol/L时对预测术后SH患者静脉补充葡萄糖酸钙>4g最有价值。结论 影响甲状腺全切术围手术期患者发生SH的相关因素较多，检测术后iPTH水平对预测患者发生SH及术后补钙量有一定价值。
Objective To investigate the related influencing factors and treatment plan of symptomatic hypocalcemia(SH) caused by secondary hypoparathyroidism during perioperative period of thyroid surgery. Methods A total of 120 patients who developed SH after total thyroidectomy were grouped as SH group, and 110 patients who did not develop SH after total thyroidectomy during the same period were grouped as control group. Logistic regression was used to analyze the influencing factors of postoperative symptomatic hypocalcemia and calcium supplement dose required for symptom relief in patients with SH; ROC curves were drawn to analyze the predictive efficacy of preoperative and postoperative full-segment parathyroid hormone(iPTH) on postoperative SH calcium supplement dose. Results Univariate analysis of SH showed that female, postoperative calcium level, preoperative iPTH, postoperative iPTH, postoperative vitamin D level, postoperative 24-hour urinary calcium level, lesion range, operation time, and pathological diagnosis were the main factors affecting SH after operation(P<0.05). univariate analysis of calcium supplement dose in SH patients showed that calcium supplement, operation time, preoperative iPTH, postoperative iPTH, postoperative vitamin D level and 24-hour urinary calcium level were the main factors affecting the calcium supplement dose required for symptom relief in SH patients after operation(P<0.05). Multivariate analysis showed that preoperative low iPTH and postoperative low iPTH were high risk factors affecting the calcium supplement dose required for symptom relief in patients with SH(P<0.05). Pearson correlation analysis showed that the calcium supplement dose required for symptom relief in postoperative SH patients was negatively correlated with preoperative iPTH and postoperative iPTH(P<0.05). ROC curve showed that postoperative iPTH <18.19 mmol/L was most significant for predicting postoperative SH patients with intravenous calcium gluconate>4 g. Conclusion There are many related factors affecting the occurrence of SH in perioperative period of total thyroidectomy. Postoperative iPTH level might serve to predict occurrence of SH and post-operative calcium supplementation.

关键词(KeyWords)： 甲状腺;症状性低钙血症;全段甲状旁腺素;钙;高危因素;处理方案
thyroid;symptomatic hypocalcemia;full segment parathyroid hormone;calcium;high risk factors;processing scheme

Abstract:

Keywords:

基金项目(Foundation): 河北省医学科学研究课题计划(20181165);; 承德市科学技术研究与发展计划项目(202109A052)

作者(Author): 齐艳涛,刘会明,李宏宇,柴吉鑫,张浏阳,李波,敖亚洲
QI Yantao,LIU Huiming,LI Hongyu,CHAI Jixin,ZHANG Liuyang,LI Bo,AO Yazhou

DOI: 10.19367/j.cnki.2096-8388.2023.07.019

参考文献(References)：

• [1] GERGES D,GROHMANN N,TRIEU V,et al.Effect of PPIs on symptomatic hypocalcemia after thyroidectomy:a retrospective cohort study[J].Laryngoscope Investig Otolaryngol,2021,6(1):150-154.
• [2] SANTOSH M,THAVAROOL S B,VIJAY S,et al.Early calcium supplementation after total thyroidectomy can prevent symptomatic hypocalcemia-findings from a retrospective study[J].Guly J Oncolog,2019,1(29):60-65.
• [3] RAJAN S,RAVINDHRAN B,GEORGE B,et al.Parathormone decline levels are better markers of symptomatic hypocalcemia following total thyroidectomy than parathormone alone[J].Biomark Med,2020,14(12):1121-1126.
• [4] IIJIMA T,JOJIMA T,HOSONUMA S,et al.Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease:longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy[J].Endocr J,2021,68(10):1187-1195.
• [5] 徐浩，朱林峰，孙举来，等.甲状腺全切术后甲状旁腺功能降低的原因及补钙疗效分析[J].蚌埠医学院学报，2020,45(8):1029-1032,1036.
• [6] LEE J W,KIM J K,KWON H,et al.Routine low-dose calcium supplementation after thyroidectomy does not reduce the rate of symptomatic hypocalcemia:a prospective randomized trial[J].Ann Surg Treat Res,2019,96(4):177-184.
• [7] XING T,HU Y,WANG B,et al.Role of oral calcium supplementation alone or with vitamin D in preventing post-thyroidectomy hypocalcaemia:a meta-analysis[J].Medicine(Baltimore),2019,98(8):e14455.
• [8] PINARDO H,RUBIN S J,HASHEMI S,et al.The use of vitamin D in preventing post-thyroidectomy hypocalcemia:An endocrinologist survey study[J].Clin Endocrinol (Oxf),2020,93(5):598-604.
• [9] 邵丙杨.高钙血症与低钙血症[J].德国医学，2001,18(2):75-76.
• [10]韩周桥，李同昌.继发性甲状旁腺功能亢进围手术期重度低钙血症的预测因素及治疗策略[J].哈尔滨医科大学学报，2020,54(1):95-98.
• [11]谭洁，边学海.甲状腺围手术期甲状旁腺素监测的临床应用及进展[J].中国普通外科杂志，2020,29(5):611-617.
• [12]孙秋红，刘京平，娄菁，等.甲状腺乳头状癌患者术后发生甲状旁腺功能减退症的影响因素分析[J].癌症进展，2022,20(9):915-917,926.
• [13]张小华，章社民，孙小虎.术前及术后补充钙与骨化三醇对全甲状腺切除术后低钙血症的影响[J].中国现代普通外科进展，2022,25(10):829-831.
• [14]DEL RIO P,ROSSINI M,MONTANA C M,et al.Postoperative hypocalcemia:analysis of factors influencing early hypocalcemia development following thyroid surgery[J].BMC Surg,2019,18(Suppl 1):25.
• [15]郝国强，邢壮杰，邓芝徽，等.继发性甲状旁腺功能亢进行甲状旁腺全切除术后低钙血症的防治[J].安徽医药，2019,23(10):1998-2000.
• [16]ALQAHTANI S M,ALATAWI A S,ALALAWI Y S.Post-Thyroidectomy hypocalcemia:a single-center experience[J].Cureus,2021 ,13(11):e20006.
• [17]陈良冬，卓德强，龚静，等.基于贝叶斯网络模型分析甲状腺乳头状癌患者术后低钙血症发生的相关因素[J].疑难病杂志，2022,21(4):344-349.
• [18]Al QUBAISI M,HAIGH P I.Hypocalcemia after total thyroidectomy in graves disease[J].Perm J,2019,23:18-188.
• [19]PADURARU D N,ION D,CARSOTE M,et al.Post-thyroidectomy hypocalcemia-risk factors and management[J].Chirurgia (Bucur),2019,114(5):564-570.
• [20]RAJAN S,RAVINDHRAN B,GEORGE B,et al.Parathormone decline levels are better markers of symptomatic hypocalcemia following total thyroidectomy than parathormone alone[J].Biomark Med,2020,14(12):1121-1126.
• [21]李岚，刘畅，肖明.预测甲状腺术后发生低钙血症的风险列线图模型建立[J].重庆医学，2021,50(3):461-465.
• [22]王晨一，代权伟，李建华，等.甲状腺术后症状性低钙血症的危险因素分析[J].国际外科学杂志，2021,48(3):179-184.
• [23]杜伟，范杰，张晓军，等.甲状腺乳头状癌根治术后发生甲状旁腺功能损伤危险因素探析[J].中国普外基础与临床杂志，2021,28(7):878-883.
• [24]ZHOU J,JU H,MA H,et al.Clinical efficacy of modified small incision thyroidectomy and analysis of influencing factors of postoperative hypocalcemia[J].Front Surg,2022,9:905920.
• [25]成铭，黄碧红，陶冶，等.维持性血液透析继发性甲状旁腺功能亢进患者甲状旁腺切除术后低钙血症的危险因素分析[J].中华肾脏病杂志，2022,38(5) :397-405.
• [26]董丽英，李燕，李思齐，等.引流液甲状旁腺激素测定对甲状腺术后甲状旁腺功能评估的临床意义[J].中国普外基础与临床杂志，2019,26(10):1196-1200.

文章评论(Comment)：